A detailed history of Hoey Investments, Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hoey Investments, Inc holds 13 shares of VRTX stock, worth $5,306. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 13 -0.0%
Holding current value
$5,306
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$283.23 - $323.1 $56,646 - $64,620
-200 Reduced 93.9%
13 $4,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $54,766 - $61,105
200 Added 1538.46%
213 $62,000
Q1 2022

Apr 25, 2022

BUY
$221.42 - $260.97 $2,878 - $3,392
13 New
13 $3,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Hoey Investments, Inc Portfolio

Follow Hoey Investments, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoey Investments, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hoey Investments, Inc with notifications on news.